CLINICAL TRIALS PROFILE FOR NORMODYNE

All Clinical Trials for NORMODYNE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02299414 ↗	Chronic Hypertension and Pregnancy (CHAP) Project	Active, not recruiting	Arrowhead Regional Medical Center	Phase 4	2015-06-01	The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective and safe.
NCT02299414 ↗	Chronic Hypertension and Pregnancy (CHAP) Project	Active, not recruiting	Aurora Health Care	Phase 4	2015-06-01	The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective and safe.
NCT02299414 ↗	Chronic Hypertension and Pregnancy (CHAP) Project	Active, not recruiting	Baylor College of Medicine	Phase 4	2015-06-01	The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective and safe.
NCT02299414 ↗	Chronic Hypertension and Pregnancy (CHAP) Project	Active, not recruiting	Bayview Medical Center	Phase 4	2015-06-01	The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective and safe.
NCT02299414 ↗	Chronic Hypertension and Pregnancy (CHAP) Project	Active, not recruiting	Beaumont Hospital	Phase 4	2015-06-01	The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective and safe.
NCT02299414 ↗	Chronic Hypertension and Pregnancy (CHAP) Project	Active, not recruiting	Brown (WIHRI)	Phase 4	2015-06-01	The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective and safe.
NCT02299414 ↗	Chronic Hypertension and Pregnancy (CHAP) Project	Active, not recruiting	Case Western/Metro Health	Phase 4	2015-06-01	The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective and safe.

Clinical Trial Conditions for NORMODYNE

Condition Name

Condition Name for NORMODYNE
Intervention	Trials
Postpartum Preeclampsia	1
Hypertension	1
Hypertension in Pregnancy	1

Condition MeSH

Condition MeSH for NORMODYNE
Intervention	Trials
Hypertension	2
Hypertension, Pregnancy-Induced	1
Pre-Eclampsia	1

Clinical Trial Locations for NORMODYNE

Trials by Country

Trials by Country for NORMODYNE
Location	Trials
United States	30

Trials by US State

Trials by US State for NORMODYNE
Location	Trials
Wisconsin	1
Utah	1
Texas	1
Tennessee	1
South Carolina	1

Clinical Trial Progress for NORMODYNE

Clinical Trial Phase

Clinical Trial Phase for NORMODYNE
Clinical Trial Phase	Trials
Phase 4	2

Clinical Trial Status

Clinical Trial Status for NORMODYNE
Clinical Trial Phase	Trials
Not yet recruiting	1
Active, not recruiting	1

Clinical Trial Sponsors for NORMODYNE

Sponsor Name

Sponsor Name for NORMODYNE
Sponsor	Trials
University of Kansas Medical Center	1
Intermountain Health Care, Inc.	1
Virtua Medical Group	1

Sponsor Type

Sponsor Type for NORMODYNE
Sponsor	Trials
Other	69
NIH	1